Search Results - "Samassa, Francesco"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye by Lanzetta, Paolo, Rassu, Nicolò, Sarao, Valentina, Samassa, Francesco, Danese, Carla, Veritti, Daniele, Bertoli, Federica, Gambato, Tommaso

    Published in Journal of ophthalmology (2020)
    “…The novel pandemic coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has challenged the medical…”
    Get full text
    Journal Article
  2. 2

    Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision by Veritti, Daniele, Grego, Lisa, Samassa, Francesco, Sarao, Valentina, Lanzetta, Paolo

    Published in Journal of cataract and refractive surgery (01-05-2020)
    “…A new scleral fixation technique of a single-piece acrylic foldable intraocular lens (IOL) (enVista MX60, Bausch & Lomb, Inc.) through a 1.80 mm corneal…”
    Get full text
    Journal Article
  3. 3

    "The blinding disease". The history of trachoma in Italians between the 19th and 20th centuries: colonial or national blindness? by Martini, Mariano, Riccardi, Niccolò, Simonetti, Omar, Orsini, Davide, Samassa, Francesco, Parodi, Alessandra

    Published in Pathogens and global health (01-09-2024)
    “…Trachoma is one of the oldest known causes of blindness in humans and it is caused by the intracellular Gram-negative bacterium serovars A, B, Ba and C. Its…”
    Get full text
    Journal Article
  4. 4

    Routine use of filtered air as endotamponade in the management of primary rhegmatogenous retinal detachment by Rapizzi, Emilio, Barosco, Guido, Zemella, Nicola, Samassa, Francesco, Rassu, Nicolò, Frattolillo, Antonio, Buratto, Lenni

    Published in European journal of ophthalmology (01-05-2024)
    “…Purpose To evaluate the safety and efficacy of filtered air as endotamponade in the management of primary rhegmatogenous retinal detachment (RRD) treated with…”
    Get full text
    Journal Article
  5. 5

    Fluocinolone acetonide for the treatment of diabetic macular edema by Veritti, Daniele, Sarao, Valentina, Diplotti, Laura, Samassa, Francesco, Lanzetta, Paolo

    Published in Expert opinion on pharmacotherapy (22-09-2017)
    “…Fluocinolone acetonide intravitreal implant is a non-erodible implant approved for the treatment of diabetic macular edema (DME) insufficiently responsive to…”
    Get more information
    Journal Article
  6. 6

    State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration by Veritti, Daniele, Sarao, Valentina, Samassa, Francesco, Danese, Carla, Löwenstein, Anat, Schmidt-Erfurth, Ursula, Lanzetta, Paolo

    Published in Expert opinion on pharmacotherapy (02-05-2020)
    “…Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the industrialized world. While effective treatment is…”
    Get more information
    Journal Article
  7. 7

    Advances in pharmacotherapy for wet age-related macular degeneration by Santarelli, Martina, Diplotti, Laura, Samassa, Francesco, Veritti, Daniele, Kuppermann, Baruch D, Lanzetta, Paolo

    Published in Expert opinion on pharmacotherapy (13-08-2015)
    “…In developed countries, neovascular age-related macular degeneration (AMD) is the leading cause of irreversible central blindness. Although AMD pathogenesis is…”
    Get more information
    Journal Article